Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon for Post-Roux-en-Y Gastric Bypass Hypoglycemia
NCT02733848Phase 1Terminated
- Sponsor
- East Carolina University
- Start
- Feb 2014
- Primary completion
- Jan 2018
- Modality
- Replacement Enzymes
01
Overview
Phase 1, single-blind trial of pancreatin in hypoglycemia (3 arms), sponsored by East Carolina University. Primary endpoint: Frequency of Hypoglycemia at 2 years. Started Feb 2014; status: terminated.
02
Drugs
pancreatin
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02733848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733848.